Organisation paid for research Program year 2025 Source: CMS Open Payments

Vitiligo & Pigmentation Institute

Neither a doctor nor a teaching hospital

Research payments

$350,281

5 payments

Through program year 2025, Vitiligo & Pigmentation Institute is reported as receiving $350,281 in research payments, across 5 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$75,281	2
2024	Research	$171,960	2
2023	Research	$103,040	1

Breakdown

Who paid Research payments · program years 2023–2025

Incyte Corporation $350,000 4 payments
Takeda Pharmaceuticals U.S.A., Inc. $281 1 payment

Studies the money was for Research payments · program years 2023–2025

Vitiligo: A Retrospective Detailed Assessment of the Clinical and Laboratory Spectrum of Disease $275,000 3 payments
Vitiligo: A Retrospective Detailed Assessment of the Clinical and Laboratory Spectrum of Disease $75,000 1 payment
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Zasocitinib in Participants with Nonsegmental Vitiligo. $281 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.